Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

NCT07180745 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease NAFLD
Non-alcoholic Steatohepatitis NASH

Interventions

DRUG: Pioglitazone (PIO)
DRUG: Empagliflozin
DRUG: Statin (Atorvastatin)
DRUG: Empagliflozin plus Statin (Atorvastatin)
DRUG: Pioglitazone plus Atorvastatin

Sponsor

Badr University